(Q45863222)

17 December 2017

title

Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies (English)

1 reference

17 December 2017

1 reference

1 reference

3

1 reference

17 December 2017

author name string

Ong HT

1

1 reference

17 December 2017

Hasegawa K

2

1 reference

17 December 2017

Russell SJ

4

1 reference

17 December 2017

Peng KW

5

1 reference

17 December 2017

publication date

19 October 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

page(s)

324-333

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302880

exact match

0 references

cites work

Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Oncolytic measles viruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Systemic therapy of myeloma xenografts by an attenuated measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Interaction of measles virus vectors with Auger electron emitting radioisotopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Synergistic antitumor effects of immune cell-viral biotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Adoptive-cell-transfer therapy for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Measles antibody: reevaluation of protective titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Measles virus infection causes transient depletion of activated T cells from peripheral circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Supernatural T cells: genetic modification of T cells for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

SLAM (CDw150) is a cellular receptor for measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Oncolytic measles virus targets high CD46 expression on multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

Rescue and propagation of fully retargeted oncolytic measles viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

7 January 2021

Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

7 January 2021

Assessing tumors in living animals through measurement of urinary beta-human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

7 January 2021

Plasma perfusion by apheresis through a gal immunoaffinity column successfully depletes anti-Gal antibody: experience with 275 aphereses in baboons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302880

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302880

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017